Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciSparc Ltd. ( (SPRC) ) has shared an update.
Shareholders approved all proposals presented at the February 4, 2026 special general meeting, affirming SciSparc’s governance agenda and regulatory compliance plan, which may streamline future capital and operational initiatives by ensuring alignment with Israeli corporate law and existing SEC-registered offerings.
More about SciSparc Ltd.
SciSparc Ltd. is an Israel-based specialty pharmaceutical company developing cannabinoid-based therapies for central nervous system disorders, targeting regulatory-compliant clinical applications in global markets.
Average Trading Volume: 2,100,213
Technical Sentiment Signal: Sell
Current Market Cap: $3.35M
For a thorough assessment of SPRC stock, go to TipRanks’ Stock Analysis page.